Category Archives: Uncategorized

From Macquarie Incubator: “Last week, we held our annual Pitch Final event for 2023! 🧠 We had five startups that delivered excellent pitches: Stopfalls Physio Pty Ltd, Trappi, Lagvelki, Zymedyne Therapeutics and Loop Hydrometallurgy, with three winning the night’s top prizes! Congratulations to our winners: Dave Sammut from Loop Hydrometallurgy won Best Pitch, receiving $3,000! Dr Chris Bladen from Zymedyne Therapeutics won Most Valuable Investment, receiving $5,000! Last but not least, Anna Stackpool from Stopfalls Physio Pty Ltd won the Researchers Engagement award, receiving $25,000 to put towards Macquarie University researchers and HDR students to validate, review and/or conduct commercial research activities! We want to thank our MC, Alistair Booth for helping us run the event, and our judges, Matthew Edmonds, Alan Jones, Jessica Baird Walsh, and Dan Geaves FFIA, who provided their time to listen to our startups pitch and ultimately make a tough decision on the winners. We’d…

Read more

Zymedyne Therapeutics is extremely proud of our Medicinal Chemist Ketulbhai Patel for winning the 2023 Mitacs Award for Outstanding Innovation. Ketul is a brilliant chemist and key part of Zymedyne’s team and thoroughly deserves the national recognition of this award. Zymedyne is also very grateful to the support we receive from Mitacs and hope to continue building the positive partnership we have with them and help grow Canada’s Biotechnology globally! From Mitacs: Prestigious Mitacs Awards Celebrate Canada’s Top Innovators – Mitacs

Zymedyne is pleased to announce that we have won the #Challenger Award in the #Innovation Category at the 2023 Australia New Zealand TMMRW Awards! Click to view the post below: https://www.linkedin.com/posts/connectmpid_macquariepark-ugcPost-7135434121287254016-5c9T?utm_source=share&utm_medium=member_desktop

Zymedyne Therapeutics wins 1st place in the SXSW Sydney pitch competition in the Healthcare, Biotech, Future of Medicine, category. Chris Bladen posted on LinkedIn

Zymedyne is pleased to announce a spotlight on the Campus Alberta Neuroscience LinkedIn page! From Campus Alberta: “What would you think about an effective pain relief solution that doesn’t cause weight gain, respiratory depression, or addiction? Zymedyne Therapeutics is working on a technology to do just that” View post: https://www.linkedin.com/posts/campus-alberta-neuroscience_zymedyne-therapeutics-activity-6996577577083555841-AyaH?utm_source=li_share&utm_content=feedcontent&utm_medium=g_dt_web&utm_campaign=copy

Zymedyne would like to congratulate CEO Chris Bladen on winning the “Engineering solutions for human and animal health” TENET i2c Competition at #inventures2022, (1st prize: $10,000)